Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q1 EPS of ($0.19), $0.28 better than the analyst estimate of ($0.47). Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE